Leadership Team
Martha Capps, Board President
Martha is mad as hell about Alzheimer’s disease after losing her mother, brother, and sister. She founded Mad as Hell to fund bold Alzheimer’s research and, drawing on decades of marketing and leadership experience, is building an organization that inspires urgency and accelerates progress toward a cure.
Jill Bartlett, Board Treasurer
Jill’s commitment to the fight against Alzheimer’s is deeply personal after losing her mother to the disease. A longtime nonprofit leader, she founded and led successful 5K fundraising events that united communities around meaningful causes. She now brings that experience to Mad as Hell, turning passion into meaningful fundraising impact.
Ellen Brinn, Board Member
Ellen shares a deep family connection to Alzheimer’s and a strong commitment to finding a cure. A competitive runner with the El Jefe Running Club, she has completed 12 marathons. She brings marketing expertise, resilience, and a strong network of runners and supporters to help grow awareness and support for Mad as Hell.
Jessie Capps, Board Member
Jessie’s commitment to the fight against Alzheimer’s spans generations and is rooted in her family’s experience with the disease. She has raised thousands of dollars to support Alzheimer’s causes and joined Mad as Hell to accelerate funding for bold research through Cure Alzheimer’s Fund, believing science offers the best hope for families.
Jim Clevenger, Board Member
Jim has seen firsthand the devastating impact of Alzheimer’s, losing both his mother and a beloved uncle to the disease. A lifelong athlete, former running business owner, and race director, he brings valuable event and operational expertise to Mad as Hell and is committed to advancing awareness and fundraising.
Cassie Roth, Board Member
Cassie witnessed her grandmother’s battle with Alzheimer’s as a young girl, watching a brilliant woman gradually lose her memory, independence, and ability to speak. That experience fuels her determination to end the disease. She brings financial expertise, a strong professional network, and unwavering commitment to advancing Alzheimer’s research.
